The new pathway will be costly.
Repeat the activity and the pathway will be reinforced.
A brick pathway will be constructed around the perimeter, where there are several worn benches.
In the following, local structural changes in the putative PT pathway will be described.
Conditioned pain modulation (CPM), representing a descending pain modulatory pathway, will be our secondary pain regulatory measure.
This indicates that if a genetic pathway in a tumour is blocked by a new targeted drug treatment, it is very likely that another pathway will be activated.
Specifically, the evolution from metabolite-binding RNA aptamer to biosensor integration into an engineered biosynthetic pathway will be discussed, with a focus on rational and high-throughput design.
Novel agents targeting the B-cell receptor pathway along with therapies outside of the pathway will be reviewed in this article.
It is likely that more mAbs targeting the PD-1/PD-L1 pathwillwill be approved for the treatment of a range of cancers.
Future metabolic pathway will be constructed based on the acetylglucosamine from chitin degradation.
In the case of bipartite graphs, the pathway will be composed of nodes that alternate between compounds and reactions.
